Get the Stockscreener App
20.49
7.12%
-1.57
Pre-market:
21.36
0.87
+4.25%
Phibro Animal Health Corp stock is traded at $20.49, with a volume of 287.62K.
It is down -7.12% in the last 24 hours and down -18.66% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$22.06
Open:
$22.04
24h Volume:
287.62K
Relative Volume:
1.27
Market Cap:
$829.92M
Revenue:
$982.01M
Net Income/Loss:
$14.80M
P/E Ratio:
55.38
EPS:
0.37
Net Cash Flow:
$37.02M
1W Performance:
-12.10%
1M Performance:
-18.66%
6M Performance:
-6.82%
1Y Performance:
+60.96%
1-Day Range:
$20.34
$22.04
1-Week Range:
$20.34
$23.78
52-Week Range:
$11.98
$26.55
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
20.49 | 829.92M | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
160.06 | 71.67B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.44B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.97B | 612.78M | -86.37M | -62.91M | -0.87 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
Phibro at Barclays Healthcare Conference: Strategic Growth Insights - Investing.com
Insider Buying: E Corcoran Acquires Additional Shares of Phibro Animal Health Corp (PAHC) - GuruFocus.com
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to “Hold” at StockNews.com - Defense World
Does Phibro Animal Health Corp (NASDAQ: PAHC) Offer Growth And Stability? - Stocks Register
Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report? - Yahoo Finance
Principal Financial Group Inc. Increases Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
When and Where to Hear Phibro Animal Health's Latest Investor Insights Next March - StockTitan
Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference - Yahoo Finance
Phibro Animal Health Corp. to Host Earnings Call - ACCESS Newswire
Is PAHC Stock a Smart Addition to Your Portfolio Right Now? - Yahoo Finance
Ieq Capital LLC Acquires Shares of 14,358 Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Zacks.com featured highlights Brinker, AppLovin and Phibro Animal Health - Yahoo Finance
Phibro Animal Health director Thomas Corcoran acquires $110,500 in stock - Investing.com India
Phibro Animal Health director Thomas Corcoran acquires $110,500 in stock By Investing.com - Investing.com South Africa
New York State Teachers Retirement System Grows Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Zacks Research Issues Optimistic Outlook for PAHC Earnings - Defense World
Csenge Advisory Group Buys Shares of 20,687 Phibro Animal Health Co. (NASDAQ:PAHC) - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Shares Down 6.5%Should You Sell? - MarketBeat
Inside Look: What Phibro's CFO Will Reveal to Wall Street About Animal Health Market Future - StockTitan
Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Sets New 1-Year HighHere's What Happened - MarketBeat
Phibro Anim stock soars to 52-week high, hits $26.5 - Investing.com
Phibro Anim stock soars to 52-week high, hits $26.5 By Investing.com - Investing.com South Africa
Zacks.com featured highlights include General Motors, Expedia Group, Phibro Animal Health and Pilgrim's Pride - Yahoo Finance
Poultry Vaccines Market Sales Statistics, Growth Outlook and Developments To 2032 | Elanco, Zoetis,Ceva, Phibro Corp.,MSD,Virbac, Hipra - The Globe and Mail
Poultry Vaccines Market Sales Statistics, Growth Outlook - openPR
Contrasting Phibro Animal Health (NASDAQ:PAHC) & Trevi Therapeutics (NASDAQ:TRVI) - Defense World
Phibro Animal Health (NASDAQ:PAHC) Sets New 12-Month High After Analyst Upgrade - MarketBeat
Best Value Stocks To Buy For February 14th - Benzinga
Best Momentum Stocks to Buy for February 14th - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Stock Price Up 6.8% on Analyst Upgrade - MarketBeat
Barclays Issues Positive Forecast for Phibro Animal Health (NASDAQ:PAHC) Stock Price - MarketBeat
Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know - Yahoo Finance Australia
Barclays lifts Phibro Animal Health target to $22, keeps underweight rating - MSN
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro (PAHC) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Stock Rating Lowered by StockNews.com - MarketBeat
Phibro Animal Health Co. to Issue Quarterly Dividend of $0.12 (NASDAQ:PAHC) - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Issues Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up After Strong Earnings - MarketBeat
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12 - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Releases FY 2025 Earnings Guidance - MarketBeat
Barclays lifts Phibro Animal Health target to $22, keeps underweight rating By Investing.com - Investing.com South Africa
Phibro Animal Health (NASDAQ:PAHC) Updates FY 2025 Earnings Guidance - Armenian Reporter
Phibro Animal Health (NASDAQ:PAHC) Announces Earnings Results - Armenian Reporter
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2025 Earnings Call Transcript - Insider Monkey
Morgan Stanley Lifts Price Target on Phibro Animal Health to $27 From $25, Keeps Equalweight Rating - Marketscreener.com
PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase - Yahoo Finance
Phibro Animal Health Corporation Reports Strong Second Quarter Results and Updates Financial Guidance - Armenian Reporter
Phibro Animal Health Corp (PAHC) Q2 2025 Earnings Call Highlight - GuruFocus.com
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):